GENEART AG Continues Profitable Growth in the First Half-Year 2007
Regensburg, Germany, August 9, 2007 - with positive market conditions in the core business of gene synthesis and a promising outlook in synthetic biology, GENEART was able to markedly increase net sales and earnings in the first half-year and expand its long-term market position.